Measurements in the intensive care unit: what do they mean?

Intensivists depend upon a large number of measurements to make daily decisions in the ICU. However, the reliability of these measures may be jeopardized by the effects of therapy. Moreover, in critical illness, what is normal is not necessarily optimal. Procalcitonin, a putative marker of occult infection, is emerging as a valuable diagnostic marker in the ICU. Although questions remain regarding its specificity, an increasing body of work suggests that it is reliably elevated in the setting of infection. As demonstrated by Level and colleagues in this issue of Critical Care, its utility as a diagnostic marker is not affected by concomitant hemodialysis.

[1]  D. Maki,et al.  A semiquantitative culture method for identifying intravenous-catheter-related infection. , 1977, The New England journal of medicine.

[2]  B. Riou,et al.  Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Cook,et al.  Procalcitonin as a diagnostic test for sepsis: health technology assessment in the ICU. , 2003, Journal of critical care.

[4]  A. Kribben,et al.  Procalcitonin for accurate detection of infection in haemodialysis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  F. Kern,et al.  Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies , 2001, Intensive Care Medicine.

[6]  F. Gorus,et al.  Plasma procalcitonin and C-reactive protein in acute septic shock: Clinical and biological correlates , 2002, Critical care medicine.

[7]  C. Lasseur,et al.  Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure , 2003, Critical care.

[8]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[9]  M. Meisner,et al.  Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. , 2001, Shock.

[10]  E. Polati,et al.  Comparison of procalcitonin and C-reactive protein as markers of sepsis. , 2003, Critical care medicine.

[11]  D. Pittet,et al.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. , 2001, American journal of respiratory and critical care medicine.

[12]  J. White,et al.  Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. , 1998, Critical care medicine.

[13]  M. Assicot,et al.  High serum procalcitonin concentrations in patients with sepsis and infection , 1993, The Lancet.

[14]  S. Kleinman,et al.  A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care , 1999 .